RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/23893245http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/23893245http://www.w3.org/2000/01/rdf-schema#comment"Sgf29, a component of the SPT-ADA-GCN5 acetyltransferase (SAGA) complex, binds H3K4me2/3 marks and leads to histone H3 acetylation. Previously, we found that downregulation of Sgf29 suppresses c-Myc-mediated malignant transformation. Nonetheless, the upstream regulator of the Sgf29 gene is not yet known. Here, we report that Sry (sex-determining region Y), an HMG (high-mobility group) domain containing transcription factor, directly upregulates Sgf29 gene expression. Sry expression was deregulated in two out of the four tested male rodent hepatocellular carcinoma (rHCC) cell lines. Luciferase reporter and chromatin immunoprecipitation assays indicated that Sry could bind HMG-boxes in the proximal promoter region of the Sgf29 gene. Knockdown of Sry robustly lowered anchorage-independent growth, invasiveness and tumorigenicity of rHCC cells, whereas ectopic expression of Sry conferred more malignant properties. Thus, these data show that Sry is involved in male-specific malignant conversion of rHCCs via Sgf29 upregulation."xsd:string
http://purl.uniprot.org/citations/23893245http://purl.org/dc/terms/identifier"doi:10.1038/onc.2013.262"xsd:string
http://purl.uniprot.org/citations/23893245http://purl.uniprot.org/core/author"Sato T."xsd:string
http://purl.uniprot.org/citations/23893245http://purl.uniprot.org/core/author"Shibata T."xsd:string
http://purl.uniprot.org/citations/23893245http://purl.uniprot.org/core/author"Tashiro F."xsd:string
http://purl.uniprot.org/citations/23893245http://purl.uniprot.org/core/author"Murakami S."xsd:string
http://purl.uniprot.org/citations/23893245http://purl.uniprot.org/core/author"Akiyama H."xsd:string
http://purl.uniprot.org/citations/23893245http://purl.uniprot.org/core/author"Kawasaki Y."xsd:string
http://purl.uniprot.org/citations/23893245http://purl.uniprot.org/core/author"Kurabe N."xsd:string
http://purl.uniprot.org/citations/23893245http://purl.uniprot.org/core/author"Sakamoto E."xsd:string
http://purl.uniprot.org/citations/23893245http://purl.uniprot.org/core/author"Uemoto H."xsd:string
http://purl.uniprot.org/citations/23893245http://purl.uniprot.org/core/author"Chishima S."xsd:string
http://purl.uniprot.org/citations/23893245http://purl.uniprot.org/core/date"2014"xsd:gYear
http://purl.uniprot.org/citations/23893245http://purl.uniprot.org/core/name"Oncogene"xsd:string
http://purl.uniprot.org/citations/23893245http://purl.uniprot.org/core/pages"2978-2986"xsd:string
http://purl.uniprot.org/citations/23893245http://purl.uniprot.org/core/title"The male-specific factor Sry harbors an oncogenic function."xsd:string
http://purl.uniprot.org/citations/23893245http://purl.uniprot.org/core/volume"33"xsd:string
http://purl.uniprot.org/citations/23893245http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/23893245
http://purl.uniprot.org/citations/23893245http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/23893245
http://purl.uniprot.org/uniprot/#_P0C606-mappedCitation-23893245http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23893245
http://purl.uniprot.org/uniprot/#_A6I9A1-mappedCitation-23893245http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23893245
http://purl.uniprot.org/uniprot/#_A6I9A2-mappedCitation-23893245http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23893245
http://purl.uniprot.org/uniprot/#_A6I9A3-mappedCitation-23893245http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23893245
http://purl.uniprot.org/uniprot/#_Q8CGQ4-mappedCitation-23893245http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/23893245